13G Filing: Taylor Asset Management Trims Stake in Can Fite Biopharma Ltd. (CANF)

Page 6 of 6

Page 6 of 6 SEC Filing

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
February 19, 2016
 
 
Date
 
     
 
/s/ Caroline Levitt
 
 
Signature
 
     
 
Caroline Levitt, Chief Financial Officer
and Chief Operating Officer
 
 
Name/Title
 
Page 6 of 6 pages

Page 6 of 6